Who owns Repare Therapeutics Ord?
- Ticker: RPTX
- CUSIP Number: 760273102
Tip: Access positions for across all investors
Analyze quarterly positions in Repare Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Repare Therapeutics Ord stock
Who bought or sold Repare Therapeutics Ord this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
---|---|---|---|---|---|---|
OrbiMed Advisors | 3.4M | $118M | 0% | Dec 2020 | ||
MPM Asset Management | 3.0M | $103M | 0% | Dec 2020 | ||
BVF | 3.0M | $102M | -3% | Dec 2020 | ||
FMR | 2.8M | $95M | 0% | Dec 2020 | ||
Redmile Group | 2.6M | $91M | 10% | Dec 2020 | ||
CHI Advisors | 2.5M | $87M | 0% | Dec 2020 | ||
MPM Oncology Impact Management | 2.4M | $82M | 0% | Dec 2020 | ||
Logos Global Management | 677k | $23M | -31% | Dec 2020 | ||
ARK Investment Management | 635k | $22M | 100% | Dec 2020 | ||
Artal Group | 570k | $20M | 0% | Dec 2020 | ||
Franklin Resources | 493k | $17M | -2% | Dec 2020 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Repare Therapeutics Ord? |
||||||
RA Capital Management | 409k | $14M | 0% | Dec 2020 | ||
BlackRock | 364k | $13M | 100% | Dec 2020 | ||
Point72 Asset Management | 303k | $10M | 100% | Dec 2020 | ||
Cormorant Asset Management | 300k | $10M | -14% | Dec 2020 | ||
Clough Capital Partners | 281k | $9.6M | 39% | Dec 2020 | ||
Sphera Funds Management | 224k | $7.7M | -8% | Dec 2020 | ||
Bank Of Montreal | 218k | $9.2M | 5300% | Dec 2020 | ||
Ubs Global Asset Management Americas | 177k | $6.1M | -6% | Dec 2020 | ||
Millennium Management | 95k | $3.3M | -50% | Dec 2020 | ||
Alyeska Investment Group | 50k | $1.7M | -67% | Dec 2020 | ||
EcoR1 Capital | 50k | $1.7M | 0% | Dec 2020 | ||
Morgan Stanley | 39k | $1.3M | 80% | Dec 2020 | ||
Vanguard Group | 31k | $1.1M | 100% | Dec 2020 | ||
CalPERS | 27k | $929k | 8% | Dec 2020 | ||
Athanor Capital | 22k | $744k | 100% | Dec 2020 | ||
Geode Capital Management | 21k | $734k | 0% | Dec 2020 | ||
Schonfeld Strategic Advisors | 21k | $728k | 100% | Dec 2020 | ||
Swiss National Bank | 21k | $713k | 100% | Dec 2020 | ||
Hrt Financial | 20k | $675k | 100% | Dec 2020 | ||
Ensign Peak Advisors | 19k | $666k | 0% | Dec 2020 | ||
Goldman Sachs Group | 18k | $613k | 100% | Dec 2020 | ||
T. Rowe Price Associates | 17k | $578k | 100% | Dec 2020 | ||
Norges Bank Investment Management | 15k | $513k | 100% | Dec 2020 | ||
Pentwater Capital Management | 14k | $463k | 59% | Dec 2020 | ||
DekaBank Deutsche Girozentrale | 13k | $440k | 100% | Dec 2020 | ||
Susquehanna Fundamental Investments | 13k | $430k | -28% | Dec 2020 | ||
Citadel Advisors | 12k | $396k | 46% | Dec 2020 | ||
Tudor Investment Corporation | 12k | $395k | -51% | Dec 2020 | ||
Allianz Asset Management | 10k | $352k | 100% | Dec 2020 | ||
Hershey Trust Company | 7.6k | $261k | 100% | Dec 2020 | ||
L & S Advisors | 7.5k | $257k | 100% | Dec 2020 | ||
Virtus ETF Advisers | 7.5k | $256k | 100% | Dec 2020 | ||
Susquehanna International | 6.3k | $216k | 100% | Dec 2020 | ||
Bank of New York Mellon | 6.2k | $213k | 100% | Dec 2020 | ||
State Street Corporation | 6.0k | $207k | 100% | Dec 2020 | ||
Cubist Systematic Strategies | 3.3k | $113k | 100% | Dec 2020 | ||
Gilder, Gagnon, Howe & Co | 3.2k | $111k | 0% | Dec 2020 | ||
Banque Cantonale Vaudoise | 3.0k | $103k | 50% | Dec 2020 | ||
Wells Fargo & Company | 2.6k | $87k | 100% | Dec 2020 | ||
Tower Research Capital | 1.8k | $0 | 90200% | Dec 2020 | ||
Citigroup | 1.2k | $42k | 100% | Dec 2020 | ||
Bank of America Corporation | 939.00 | $32k | 100% | Dec 2020 | ||
Penserra Capital Management | 845.00 | $28k | 100% | Dec 2020 | ||
Royal Bank of Canada | 729.00 | $24k | 264% | Dec 2020 | ||
Great-West Life Assurance Company | 676.00 | $23k | 100% | Dec 2020 | ||
IFP Advisors | 200.00 | $7.0k | 100% | Dec 2020 | ||
UBS Group | 200.00 | $7.0k | -70% | Dec 2020 | ||
CWM | 100.00 | $3.0k | 100% | Dec 2020 | ||
Daiwa Securities Group | 69.00 | $2.0k | 100% | Dec 2020 | ||
Jpmorgan Chase & Co | 27.00 | $0 | 100% | Dec 2020 | ||
Hm Payson & Co | 2.00 | $0 | 0% | Dec 2020 |
Who sold out of Repare Therapeutics Ord?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Ikarian Capital | Sep 2020 | 190k | $5.9M |
Caas Capital Management | Sep 2020 | 50k | $1.5M |
Boothbay Fund Management | Sep 2020 | 22k | $661k |